Showing results (81-90 of 554) with videos related to
Sort By:
Pageof 56
Current Opinion in Pharmacology|November 6, 2017
Modulating bile acid pathways and TGR5 receptors for treating liver and GI diseasesHarmeet Malhi, Michael CamilleriPharmacogenomics|July 8, 2017
Pharmacogenetics and the treatment of functional gastrointestinal disordersHoussam Halawi, Michael CamilleriGastroenterology|October 14, 2008
Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdlesMichael Camilleri, Lin ChangTherapeutic Advances in Gastroenterology|July 25, 2014
Elobixibat and its potential role in chronic idiopathic constipationAndres Acosta, Michael CamilleriAmerican Journal of Physiology. Gastrointestinal and Liver Physiology|September 9, 2020
Effects of dietary components on intestinal permeability in health and diseaseKatayoun Khoshbin, Michael CamilleriNeurogastroenterology and Motility|November 9, 2021
Bile Acid Diarrhea in Adults and AdolescentsMichael Camilleri, Samuel NurkoGastroenterology Clinics of North America|July 29, 2020
Refractory Constipation: How to Evaluate and TreatMichael Camilleri, Justin BrandlerThe American Journal of Gastroenterology|June 20, 2020
The Role of Bile Acids in Chronic DiarrheaMichael Camilleri, Priya VijayvargiyaGastroenterology & Hepatology|September 29, 2023
New Developments in Bile Acid DiarrheaMichael Camilleri, Joelle BouSabaGut|October 28, 2022
Irritable bowel syndrome: treatment based on pathophysiology and biomarkersMichael Camilleri, Guy BoeckxstaensPageof 56